Pharmafile Logo
Pharmafocus logo
Advanced Search

Genzyme

Showing 8 posts of 98 posts found.

Genzyme cuts forecasts on production problems

July 29, 2009
Manufacturing and Production, Sales and Marketing Genzyme

The contamination problems at Genzyme's Allston Landing production plants have caused the firm to scale back its revenue forecasts for …

News

Genzyme’s woes are a boost for Shire and Protalix

July 9, 2009
Research and Development, Sales and Marketing FDA, Genzyme, US

The contamination problems at a plant used by Genzyme to manufacture a drug for Gaucher disease have prompted the US …

News

Pharmaceutical manufacturing: news in brief

July 6, 2009
Manufacturing and Production Genzyme, Quotient

Pharmafocus presents a round-up of developments in manufacturing, including facility updates from Genzyme, Caraco, MSD, Rottapharm and Almac Pharma Services, …

News

Pharmaceutical manufacturing: news in brief

June 22, 2009
Manufacturing and Production Genzyme

Pharmafocus presents a round-up of developments in manufacturing, including facility updates from Genzyme, Norwich Pharma and Kemwell/Boehringer Ingelheim, progress with …

News

Genzyme buys rights to Bayer MS candidate

June 4, 2009
Sales and Marketing Bayer, Genzyme

Genzyme has bought the global rights multiple sclerosis (MS) candidate Campath/MabCampath from Bayer HealthCare.Originally discovered by Genzyme, Campath (alemtuzumab) is …

News

Pharma manufacturing: news in brief

May 12, 2009
Manufacturing and Production Genzyme

Pharmafocus presents a round-up of developments in the pharmaceutical manufacturing sector, including new capital investments at Roche, Genzyme and Aeras, …

News

Blow for Genzyme as FDA finds fault with Allston facility

March 13, 2009
Research and Development, Sales and Marketing FDA, Genzyme

The chances of approval for Genzyme's new Pompe disease drug Lumizyme have diminished dramatically after the US Food and Drug …

News

Genzyme says new plant approval is imminent

February 18, 2009
Research and Development, Sales and Marketing Genzyme

Genzyme has said it expects to get approval to make a Pompe disease treatment at a new US manufacturing unit …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026